EcoDrugPlus

Protein Kinase C Iota

Ensembl ID : ENSCHAG00000019443
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSCHAG00000018247
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSCHAG00000022082
Gene Symbol: PRKCAA
1 Cross references
212 Possible Orthologues:

Protein Kinase C, Beta A

Ensembl ID : ENSCHAG00000005747
Gene Symbol: PRKCBA
1 Cross references
201 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSCHAG00000018303
Gene Symbol: PRKCDA
1 Cross references
207 Possible Orthologues:

Protein Kinase C, Eta, B

Ensembl ID : ENSCHAG00000002501
Gene Symbol: PRKCHB
1 Cross references
161 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSCHAG00000012200
Gene Symbol: PRKD1
3 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCHAG00000008830
Gene Symbol: PRKD3
1 Cross references
218 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSCHAG00000023074
Gene Symbol: PRKDC
1 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSCHAG00000001172
Gene Symbol: PPP3CA
1 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSCHAG00000024267
Gene Symbol: PTK2
1 Cross references
247 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSCHAG00000013842
Gene Symbol: PTK2B
1 Cross references
142 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).